Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

7.54
+0.31004.29%
Post-market: 7.540.00000.00%16:30 EDT
Volume:213.57K
Turnover:1.62M
Market Cap:161.18M
PE:-1.66
High:7.90
Open:7.33
Low:7.27
Close:7.23
Loading ...
Aug 05, 2021

Major Issues Report

8-K - Current report
Jul 16, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 05, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 05, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 04, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 23, 2020

Major Issues Report

8-K - Current report